Loading...
Mesenchymal Stem (Stromal) Cells for Treatment of ARDS: A Phase 1 Clinical Trial
BACKGROUND: There is no effective pharmacotherapy for the acute respiratory distress syndrome (ARDS), and mortality remains high. Preclinical studies support the efficacy of mesenchymal stem (stromal) cells (MSCs) in the treatment of lung injury. The aim of this phase one clinical trial was to test...
Na minha lista:
Udgivet i: | Lancet Respir Med |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
2014
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4297579/ https://ncbi.nlm.nih.gov/pubmed/25529339 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2213-2600(14)70291-7 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|